Michael Slade

16PUBLICATIONS
88CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical mycologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Reaction engineering (excl. nuclear reactions)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|May 26, 2026
Indistinguishable From Magic.

|Jan 09, 2026
A single-cell atlas characterizes dysregulation of the bone marrow immune microenvironment associated with outcomes in multiple myeloma.

William C Pilcher, Lijun Yao, Edgar Gonzalez-Kozlova

|Mar 12, 2025
Memory-like NK cell differentiation, inhibitory NKG2A blockade, and improved recognition via antibody or CAR engineering combine to enhance NK cell attack against multiple myeloma.

Alice Y Zhou, Nancy D Marin, Sadia Afrin

|Jul 11, 2024
Pretransplant desensitization of donor-specific anti-HLA antibodies with plasmapheresis and immunoglobulin produces equivalent outcomes to patients with no donor specific antibodies in haploidentical hematopoietic cell transplant.

Hunter Cassidy Cochran, Michael Joseph Slade, Chang Liu

|Jul 09, 2024
Rational Protein Engineering to Enhance MHC-Independent T-cell Receptors.

Ju-Fang Chang, Jack H Landmann, Tien-Ching Chang

|May 02, 2023
Costimulatory domains direct distinct fates of CAR-driven T-cell dysfunction.

Mehmet Emrah Selli, Jack H Landmann, Marina Terekhova

Pageof 3

Frequent Collaborators

4 joint publications

Mark Fiala

3 joint publications

Nathan Singh

2 joint publications

Yu-Sung Hsu

2 joint publications

John F DiPersio